Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The challenges of type 1 diabetes and new psychoactive substance misuse

The challenges of type 1 diabetes and new psychoactive substance misuse Substance misuse, specifically novel psychoactive substances (NPSs), can have multiple effects on physical and psychological health and well‐being. This is of particular concern to people with type 1 diabetes (T1DM) as their use may impact on effective glucose management and may result in acute complications and deleterious consequences. This review aims to investigate the physical and psychological effects of NPSs and traditional illicit drug use on glycaemic control and corresponding self‐care for people with T1DM. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Practical Diabetes Wiley

The challenges of type 1 diabetes and new psychoactive substance misuse

Download PDF
6 pages

Loading next page...
 
/lp/wiley/the-challenges-of-type-1-diabetes-and-new-psychoactive-substance-K3oVfR4IH0
Publisher
Wiley
Copyright
Copyright © 2018 John Wiley & Sons, Ltd.
ISSN
2047-2897
eISSN
2047-2900
DOI
10.1002/pdi.2168
Publisher site
See Article on Publisher Site

Abstract

Substance misuse, specifically novel psychoactive substances (NPSs), can have multiple effects on physical and psychological health and well‐being. This is of particular concern to people with type 1 diabetes (T1DM) as their use may impact on effective glucose management and may result in acute complications and deleterious consequences. This review aims to investigate the physical and psychological effects of NPSs and traditional illicit drug use on glycaemic control and corresponding self‐care for people with T1DM.

Journal

Practical Diabetes – Wiley

Published: May 1, 2018

Keywords: ; ; ; ; ; ;

References

  • Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States
    Barratt, M
  • Characterising dark net marketplace purchasers in a sample of regular psycho‐stimulant users
    Van Buskirk, J
  • Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine
    Moore, K
  • Drug use among 13 and 15 year olds in Scotland 2015
  • A summary of the health harms of drugs
  • Mephedrone, ‘Bubble’ and unidentified white powders: the contested identities of synthetic ‘legal highs
    Measham, F
  • Evaluating substance use and insulin misuse in adolescents with type 1 diabetes
    Snyder, LL
  • Managing young people with type 1 diabetes in a ‘rave’ new world: metabolic complications of substance abuse in type 1 diabetes
    Lee, P
  • e‐Psychonauts: Conducting research in online drugs forum communities
    Davey, Z
  • Cannabinoid facilitation of behavioural and biochemical hedonic taste responses
    De Luca, MA
  • Diabetes care for emerging adults: Recommendations for transition from pediatric to adult diabetes care systems
    Peters, A; Laffel, L
  • Sex, drugs and chronic illness: Health behaviours among chronically ill youth
    Suris, J; Parera, N
  • Childhood trauma and initiation of drug use in adolescence
    Carliner, H
  • Recreational drug use in type 1 diabetes: an invisible accomplice to poor glycaemic control?
    Lee, P
  • Street drug use among patients with type 1 diabetes in the UK
    Ng, RSH
  • The potential dangers of mephedrone in people with diabetes: a case report
    Wong, ML; Holt, RIG
  • Recreational use of 1‐(2‐naphthyl)‐2‐(1‐pyrrolidinyl)‐1‐pentanone hydrochloride (NRG‐1), 6‐(2‐aminopropyl) benzofuran (Benzofury/ 6‐APB) and NRG‐2 with review of available evidence‐based literature
    Jebadurai, J
  • Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes
    Laing, SP
  • Substance abuse in young patients with type 1 diabetes: easily neglected in complex medical management
    Lee, P
  • Mephedrone: use, subjective effects and health risks
    Winstock, A
  • The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences
    Karila, L
  • Mephedrone (4‐methylmethcathinone): What is new in our understanding of its use and toxicity
    Wood, DM; Dargan, PI
  • A community outreach service for vulnerable people with diabetes
    Jones, M
  • Short‐ and medium‐term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta‐analysis of randomised trials
    Hirst, JA
  • Social consumption of alcohol in adolescents with type 1 diabetes is associated with increased glucose lability, but not hypoglycaemia
    Ismail, D
  • Long‐term effects of cannabis on brain structure
    Battistella, G
  • Drug abuse briefing: a guide to the non‐medical use of drugs in Britain
  • Combined use of alcohol and psychotropic drugs. A review of the literature
    Leccese, AP
  • Recreational drugs and their impact on diabetes
    Hicks, D